A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes

D Guo, M Li, Y Zhang, P Yang, S Eckenrode… - Nature …, 2004 - nature.com
D Guo, M Li, Y Zhang, P Yang, S Eckenrode, D Hopkins, W Zheng, S Purohit, RH Podolsky
Nature genetics, 2004nature.com
Previous studies have suggested more than 20 genetic intervals that are associated with
susceptibility to type 1 diabetes (T1D),, but identification of specific genes has been
challenging and largely limited to known candidate genes. Here, we report evidence for an
association between T1D and multiple single-nucleotide polymorphisms in 197 kb of
genomic DNA in the IDDM5 interval. We cloned a new gene (SUMO4), encoding small
ubiquitin-like modifier 4 protein, in the interval. A substitution (M55V) at an evolutionarily …
Abstract
Previous studies have suggested more than 20 genetic intervals that are associated with susceptibility to type 1 diabetes (T1D),, but identification of specific genes has been challenging and largely limited to known candidate genes. Here, we report evidence for an association between T1D and multiple single-nucleotide polymorphisms in 197 kb of genomic DNA in the IDDM5 interval. We cloned a new gene (SUMO4), encoding small ubiquitin-like modifier 4 protein, in the interval. A substitution (M55V) at an evolutionarily conserved residue of the crucial CUE domain of SUMO4 was strongly associated with T1D (P = 1.9 × 10−7). SUMO4 conjugates to IκBα and negatively regulates NFκB transcriptional activity. The M55V substitution resulted in 5.5 times greater NFκB transcriptional activity and ∼2 times greater expression of IL12B, an NFκB-dependent gene. These findings suggest a new pathway that may be implicated in the pathogenesis of T1D.
nature.com